# Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients

> **NCT01271556** · NA · COMPLETED · sponsor: **University of Milan** · enrollment: 20 (actual)

## Conditions studied

- Salmeterol Effect Against an Acute Alveolar Fluid Clearance Challenge Secondary to Lung Fluid Overload in COPD Patients
- Chronic Obstructive Pulmonary Disease
- Bronchodilator Agents
- Salmeterol

## Interventions

- **DRUG:** Salmeterol
- **PROCEDURE:** saline infusion (0.9 per cent sodium chloride)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01271556
- **Lead sponsor:** University of Milan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-03
- **Final completion:** 2009-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01271556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01271556, "Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01271556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*